[Abstract Only] Meta-Analysis: Monotherapy with a P2Y12 Inhibitor vs. Aspirin for Secondary Prevention in Patients with Established Atherosclerosis
8 May, 2020 | 10:07h | UTCMonotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis – The Lancet (link to abstract – $ for full-text)